Avalo Therapeutics, Inc. — DEFA14A Filings
12 DEFA14A filings on record
This page lists all DEFA14A filings submitted to the SEC by Avalo Therapeutics, Inc. (AVTX), sorted by most recent first. Each row links to the full filing on EdgarLookup. Avalo Therapeutics, Inc. has filed 12 DEFA14A documents with the SEC since 2015. To view all SEC filings by Avalo Therapeutics, Inc., see the full filings list.
All
10-K
10-K/A
10-Q
10-Q/A
144
25-NSE
3
4
4/A
424B3
424B4
424B5
425
8-A12B
8-K
8-K/A
ARS
CERTNAS
CORRESP
CT ORDER
D
DEF 14A
DEFA14A
DEFR14A
DRS
DRS/A
DRSLTR
EFFECT
FWP
POS AM
PRE 14A
PRER14A
S-1
S-1/A
S-3
S-3/A
S-4
S-4/A
S-8
S-8 POS
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| DEFA14A | DEFA14A | 0001628280-25-021313 | May 1, 2025 | — |
| DEFA14A | DEFA14A | 0001628280-24-030233 | Jun 27, 2024 | — |
| DEFA14A | DEFA14A | 0001628280-24-013442 | Mar 28, 2024 | — |
| DEFA14A | DEFA14A | 0001628280-23-040981 | Dec 7, 2023 | — |
| DEFA14A | DEFA14A | 0001628280-23-034690 | Oct 19, 2023 | — |
| DEFA14A | DEFA14A | 0001628280-22-010114 | Apr 25, 2022 | — |
| DEFA14A | DEFA14A | 0001628280-21-007748 | Apr 27, 2021 | — |
| DEFA14A | SCHEDULE 14A | 0001104659-20-052398 | Apr 28, 2020 | — |
| DEFA14A | DEFA14A | 0001104659-19-036366 | Jun 19, 2019 | — |
| DEFA14A | DEFA14A | 0001628280-18-004372 | Apr 18, 2018 | — |
| DEFA14A | DEFA14A SUPPLEMENT | 0001628280-18-004370 | Apr 18, 2018 | — |
| DEFA14A | DEFA14A | 0001628280-18-004026 | Apr 5, 2018 | — |